Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H20N2O |
Molecular Weight | 232.3214 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)N(C1CCNCC1)C2=CC=CC=C2
InChI
InChIKey=PMCBDBWCQQBSRJ-UHFFFAOYSA-N
InChI=1S/C14H20N2O/c1-2-14(17)16(12-6-4-3-5-7-12)13-8-10-15-11-9-13/h3-7,13,15H,2,8-11H2,1H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/7103030Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/14607008
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7103030
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/14607008
Norfentanyl is a major urinary metabolite of a potent, synthetic narcotic analgesic fentanyl.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Development of an enzyme-linked immunosorbent assay for fentanyl and applications of fentanyl antibody-coated nanoparticles for sample preparation. | 2006 Jun 16 |
|
Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors. | 2007 Nov 1 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
8366
Created by
admin on Sat Dec 16 04:54:49 GMT 2023 , Edited by admin on Sat Dec 16 04:54:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
62685
Created by
admin on Sat Dec 16 04:54:49 GMT 2023 , Edited by admin on Sat Dec 16 04:54:49 GMT 2023
|
PRIMARY | |||
|
259381
Created by
admin on Sat Dec 16 04:54:49 GMT 2023 , Edited by admin on Sat Dec 16 04:54:49 GMT 2023
|
PRIMARY | |||
|
89293
Created by
admin on Sat Dec 16 04:54:49 GMT 2023 , Edited by admin on Sat Dec 16 04:54:49 GMT 2023
|
PRIMARY | |||
|
216-543-3
Created by
admin on Sat Dec 16 04:54:49 GMT 2023 , Edited by admin on Sat Dec 16 04:54:49 GMT 2023
|
PRIMARY | |||
|
2MK6D8JV6J
Created by
admin on Sat Dec 16 04:54:49 GMT 2023 , Edited by admin on Sat Dec 16 04:54:49 GMT 2023
|
PRIMARY | |||
|
SUB34914
Created by
admin on Sat Dec 16 04:54:49 GMT 2023 , Edited by admin on Sat Dec 16 04:54:49 GMT 2023
|
PRIMARY | |||
|
100000128157
Created by
admin on Sat Dec 16 04:54:49 GMT 2023 , Edited by admin on Sat Dec 16 04:54:49 GMT 2023
|
PRIMARY | |||
|
1609-66-1
Created by
admin on Sat Dec 16 04:54:49 GMT 2023 , Edited by admin on Sat Dec 16 04:54:49 GMT 2023
|
PRIMARY | |||
|
DTXSID2057657
Created by
admin on Sat Dec 16 04:54:49 GMT 2023 , Edited by admin on Sat Dec 16 04:54:49 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
PARENT (METABOLITE INACTIVE)
PARENT (METABOLITE INACTIVE)
SALT/SOLVATE (PARENT)